In primary KIT+ tumor cultures, nucleated tumor cells expanded in the absence (4.6±0.4-fold), but not the presence (1.2±0.5-fold) of imatinib (p = 0.01, Figure 4A). This evidence concerns the gene KIT and neoplasm.